Clinical Trial Update: The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating three limus-eluting stents for preventing restenosis in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)
• Sirolimus-eluting stent (sirolimus-eluting stent)
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED